Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-072552
Filing Date
2024-08-26
Accepted
2024-08-26 15:00:37
Documents
1
Period of Report
2024-08-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-66848.html 4  
1 PRIMARY DOCUMENT marketforms-66848.xml 4 3373
  Complete submission text file 0001213900-24-072552.txt   4772
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 241240525